At the heart of every strong business community is connection. Networking and collaboration programs play a vital role in bringing people together — creating opportunities not only for professional ...

Iambic’s AI-platform includes Enchant, a multimodal transformer model designed to predict both preclinical and clinical endpoints, alongside NeuralPLexer. 1 Enchant recently received Nvidia HGX B200 ...

A policy brief from the Center for Global Policy has found that programs to counter violent extremism need more funding and better collaboration to make them more effective. The brief evaluated ...

SAN DIEGO and SUZHOU, China, May 04, 2023 (GLOBE NEWSWIRE) -- Adagene Inc. (ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel ...

STARKVILLE, Miss.—Mississippi State University is beginning an international education collaboration with Brazil’s Universidade de Rio Verde after the signing of a joint agreement this week. MSU ...

This collaboration creates a path for accelerating our respective oncology pipeline programs and broadening the use of Autolus’ technology outside of autologous cell therapy applications.” BioNTech ...

AstraZeneca entered a strategic collaboration with CSPC Pharmaceuticals to expand its weight management and metabolic disease pipeline, reflecting the pharmaceutical industry’s growing focus on ...

- Upon closing, Arrowhead will receive $825 million immediately, including an upfront payment and an equity investment at a 35% premium, and will receive an additional $250 million paid over five ...

Artiva Biotherapeutics, Inc., an oncology company focused on developing and commercializing primary allogeneic natural killer (NK) cell therapies to treat cancer, announced today that it has entered ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced an exclusive global licensing and ...

– Sarepta obtains exclusive worldwide licenses to four clinical-stage and three preclinical-stage programs in muscle, central nervous system, and rare pulmonary disorders, including potential ...